SCHEMBL8720336

SCHEMBL8720336

COc1ccccc1N1CCN(CCCCCCCCOc2ccccc2N2CCN(C)CC2)CC1

nearest known ligand 0.72

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.72
LMNA P02545 2/20 0.72
KDM4E B2RXH2 1/20 0.72
TDP1 Q9NUW8 1/20 0.72
MAPT P10636 1/20 0.72
NLRP1 Q9C000 1/20 0.72
HTR1A P08908 3/20 0.70
DRD2 P14416 4/20 0.69
DRD3 P35462 3/20 0.69
ADRA1A P35348 2/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
SLC6A2 P23975 1/20 0.67
SLC6A4 P31645 1/20 0.67
HTR2A P28223 3/20 0.66
HTR7 P34969 3/20 0.66
MEN1 O00255 2/20 0.66
KMT2A Q03164 2/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8724501 1.00 ALDH1A1 (0.72) ALDH1A1LMNAKDM4ETDP1MAPT
SCHEMBL8719445 1.00 ALDH1A1 (0.72) ALDH1A1LMNAKDM4ETDP1MAPT
SCHEMBL8719681 1.00 ALDH1A1 (0.72) ALDH1A1LMNAKDM4ETDP1MAPT
SCHEMBL8723284 0.91 DRD2 (0.72) ALDH1A1KDM4ETDP1HTR1ADRD2
SCHEMBL8720341 0.86 ADRA1D (0.65) ALDH1A1KDM4ETDP1HTR1ADRD2
SCHEMBL8719497 0.85 HTR1A (0.64) ALDH1A1KDM4ETDP1HTR1ADRD2
SCHEMBL8719441 0.85 HTR1A (0.64) ALDH1A1KDM4ETDP1HTR1ADRD2
SCHEMBL1114497 0.85 DRD2 (0.72) ALDH1A1LMNAKDM4ETDP1MAPT
SCHEMBL6526368 0.85 DRD2 (0.85) ALDH1A1HTR1ADRD2DRD3ADRA1A
SCHEMBL8719239 0.84 KDM4E (0.62) ALDH1A1LMNAKDM4ETDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998042692-A1 PIPERAZINES DERIVED FROM CYCLIC AMINES, PREPARATION AND APPLICATION THEREOF AS MEDICINES PIERRE FABRE MEDICAMENT (FR) 1998-10-01 WO disclosed